Open main menu

Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients (Q61975904)

clinical trial
edit
Language Label Description Also known as
English
Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
clinical trial

    Statements

    Comparison of Metformin and Pioglitazone Effects on Serum YKL-40 Concentrations in Patients With Newly Diagnosed Type 2 Diabetes (English)
    0 references
    November 2012
    0 references
    March 2013
    0 references
    84
    0 references
    0 references
    0 references
    35 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit